Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells
AUTOR(ES)
Yeh, Shuyuan
FONTE
The National Academy of Sciences
RESUMO
Although mutations of the breast cancer susceptibility gene 1 (BRCA1) may play important roles in breast and prostate cancers, the detailed mechanism linking the functions of BRCA1 to these two hormone-related tumors remains to be elucidated. Here, we report that BRCA1 interacts with androgen receptor (AR) and enhances AR target genes, such as p21(WAF1/CIP1), that may result in the increase of androgen-induced cell death in prostate cancer cells. The BRCA1-enhanced AR transactivation can be further induced synergistically with AR coregulators, such as CBP, ARA55, and ARA70. Together, these data suggest that the BRCA1 may function as an AR coregulator and play positive roles in androgen-induced cell death in prostate cancer cells and other androgen/AR target organs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=17187Documentos Relacionados
- Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor
- Androgen-induced proliferative quiescence in prostate cancer cells: The role of AS3 as its mediator
- Suppression of Δ5-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells
- Androgen-induced recruitment of RNA polymerase II to a nuclear receptor–p160 coactivator complex
- Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells.
